Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Andrew, Ashe, cell, CEO, children, confirmation, Crohn, deducting, engendered, expedite, explore, healthy, Hyaluronidase, likelihood, mast, mix, path, Retention, rheumatoid, stability, underwritten, verify, verifying
Removed:
Amgen, assuming, asterisk, Aveo, Baxter, Bayer, Bio, Biogen, Boehringer, call, center, confidential, dated, deficient, differentiation, Emergent, Idec, ImClone, IND, Ingelheim, Investigational, Kadmon, marked, maximize, Merck, Merrimack, Mitigation, Nordisk, Novo, omitted, origin, preliminary, produced, Schering, Serono, supplemental, Trubion, validation
Filing tables
Filing exhibits
Related press release
DYAX similar filings
Filing view
External links